Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,03 GBX | +1,50% | -5,58% | -69,70% |
22/02 | Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024 | |
21/02 | FTSE 100 krijgt klap in aanloop naar FOMC-notulen | AN |
Omzet 2023 * | 15,26 mln. 19,3 mln. 17,85 mln. | Omzet 2024 * | 53,03 mln. 67,05 mln. 62,01 mln. | Marktkapitalisatie | 15,64 mln. 19,78 mln. 18,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -25 mln. -31,61 mln. -29,24 mln. | Nettowinst (verlies) 2024 * | -11 mln. -13,91 mln. -12,86 mln. | EV/omzet 2023 * | 1,1 x |
Nettoschuld 2023 * | 1,17 mln. 1,47 mln. 1,36 mln. | Nettoschuld 2024 * | 14,19 mln. 17,94 mln. 16,59 mln. | EV/omzet 2024 * | 0,56 x |
K/w-verhouding 2023 * |
-0,54
x | K/w-verhouding 2024 * |
-1,37
x | Werknemers | 27 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 43,74% |
Recentste transcriptie over Shield Therapeutics plc
1 dag | +1,50% | ||
1 week | -5,58% | ||
Lopende maand | -11,74% | ||
1 maand | -18,80% | ||
3 maanden | -69,24% | ||
6 maanden | -73,64% | ||
Lopend jaar | -69,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Madison
CEO | Chief Executive Officer | 57 | 01-06-21 |
Santosh Shanbhag
DFI | Director of Finance/CFO | 47 | 16/01 |
David Childs
COO | Chief Operating Officer | - | 01-08-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 68 | 26-07-18 | |
Director/Board Member | 65 | 01-02-16 | |
Director/Board Member | 57 | 10-05-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 2,03 | +1,50% | 334 022 |
27-03-24 | 2 | 0,00% | 2 229 402 |
26-03-24 | 2 | 0,00% | 2 516 630 |
25-03-24 | 2 | -9,09% | 1 890 101 |
22-03-24 | 2,2 | +2,33% | 1 055 315 |
uitgestelde koers London S.E., 28 maart 2024 om 13:53 uur
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-69,70% | 19,75 mln. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,19% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |